# A Single Dose Study Of PF-06291874 In Healthy Adult Subjects

> **NCT01499017** · PHASE1 · TERMINATED · sponsor: **Pfizer** · enrollment: 9 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06291874 or placebo
- **DRUG:** PF-06291874 or Placebo

## Key facts

- **NCT ID:** NCT01499017
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2012-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01499017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01499017, "A Single Dose Study Of PF-06291874 In Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01499017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*